Differential expression of MHC class II molecules in highly metastatic breast cancer cells is mediated by the regulation of the CIITA transcription
Authors:
- Antònia VinyalsAVAntònia Vinyals
- Pedro AliaPAPedro Alia
- Cristina BroceñoCBCristina Broceño
- Feisong ChenFCFeisong Chen
- Marc AdroverMAMarc Adrover
- Carme GelpiCGCarme Gelpi
- Àngels FabraÀFÀngels Fabra
- 1 January 2006
- journal article
- Published by Elsevier in The International Journal of Biochemistry & Cell Biology
- Vol. 38 (4) , 544-562
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Mini‐review: Specificity and expression of CIITA, the master regulator of MHC class II genesEuropean Journal of Immunology, 2004
- Regulation of MHC class II expression in glioma cells by class II transactivator (CIITA)Glia, 2003
- Gene expression profiling of tumor xenografts: In vivo analysis of organ‐specific metastasisInternational Journal of Cancer, 2003
- Lack of ifn‐γ‐mediated induction of the class II transactivator (CIITA) through promoter methylation is predominantly found in developmental tumor cell linesInternational Journal of Cancer, 2001
- Malignant glioma cells use MHC class II transactivator (CIITA) promoters III and IV to direct IFN‐γ‐inducible CIITA expression and can function as nonprofessional antigen presenting cells in endocytic processing and CD4+ T‐cell activationGlia, 2001
- Lack of class II transactivator causes severe deficiency of HLA-DR expression in small cell lung cancerThe Journal of Pathology, 1999
- Quantitative control of MHC class II expression by the transactivator CIITAEuropean Journal of Immunology, 1998
- MHC Class II-Transfected Tumor Cells Induce Long-Term Tumor-Specific Immunity in Autologous MiceCellular Immunology, 1994
- Control of metastatic properties of BL6 melanoma cells by H-2Kb gene: immunological and nonimmunological mechanismsClinical & Experimental Metastasis, 1993
- The biology of metastatic breast cancerCancer, 1990